These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31292722)

  • 1. Timp3 deficiency affects the progression of DEN-related hepatocellular carcinoma during diet-induced obesity in mice.
    Casagrande V; Mauriello A; Anemona L; Mavilio M; Iuliani G; De Angelis L; D'Onofrio M; Arisi I; Federici M; Menghini R
    Acta Diabetol; 2019 Dec; 56(12):1265-1274. PubMed ID: 31292722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma.
    Casagrande V; Mauriello A; Bischetti S; Mavilio M; Federici M; Menghini R
    Sci Rep; 2017 Jul; 7(1):6747. PubMed ID: 28751722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
    Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
    Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice.
    Menghini R; Menini S; Amoruso R; Fiorentino L; Casagrande V; Marzano V; Tornei F; Bertucci P; Iacobini C; Serino M; Porzio O; Hribal ML; Folli F; Khokha R; Urbani A; Lauro R; Pugliese G; Federici M
    Gastroenterology; 2009 Feb; 136(2):663-72.e4. PubMed ID: 19027012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
    Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
    BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
    Wang B; Hsu SH; Majumder S; Kutay H; Huang W; Jacob ST; Ghoshal K
    Oncogene; 2010 Mar; 29(12):1787-97. PubMed ID: 20023698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
    Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
    BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMP3 controls cell fate to confer hepatocellular carcinoma resistance.
    Defamie V; Sanchez O; Murthy A; Khokha R
    Oncogene; 2015 Jul; 34(31):4098-108. PubMed ID: 25347747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
    Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
    Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure.
    Hsu SH; Wang B; Kutay H; Bid H; Shreve J; Zhang X; Costinean S; Bratasz A; Houghton P; Ghoshal K
    Am J Pathol; 2013 Dec; 183(6):1719-1730. PubMed ID: 24113455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
    Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.
    Zhang W; Hou J; Wang X; Jiang R; Yin Y; Ji J; Deng L; Huang X; Wang K; Sun B
    Oncotarget; 2015 Apr; 6(11):9420-33. PubMed ID: 25826083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.
    Meng Z; Wang X; Gan Y; Zhang Y; Zhou H; Ness CV; Wu J; Lou G; Yu H; He C; Xu R; Huang W
    J Hepatol; 2012 Nov; 57(5):1004-12. PubMed ID: 22728874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity phenotype induced by high-fat diet promotes diethylnitrosamine (DEN)-induced precancerous lesions by M1 macrophage polarization in mice liver.
    Tian L; Zuoqin D; Jiaqi W; Xiaomeng J; Xin D; Yan Y; Youkun Z; Jianbo W
    J Nutr Biochem; 2024 Mar; 125():109566. PubMed ID: 38176623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.
    Park TJ; Kim JY; Oh SP; Kang SY; Kim BW; Wang HJ; Song KY; Kim HC; Lim IK
    Hepatology; 2008 May; 47(5):1533-43. PubMed ID: 18393292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diethylnitrosamine-Induced Liver Tumorigenesis in Mice Under High-Hat High-Sucrose Diet: Stepwise High-Resolution Ultrasound Imaging and Histopathological Correlations.
    Cordier P; Sangouard F; Fang J; Kabore C; Desdouets C; Celton-Morizur S
    Methods Mol Biol; 2024; 2769():27-55. PubMed ID: 38315387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
    Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
    J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.